Ying-Hong Hao

Statistics

Publications

Citations

H-Index

Active since

2020

Affiliations

University of Science and Technology of China(Current)

Ying-Hong Hao is an author at University of Science and Technology of China specializing in pharmacology, hepatocellular carcinoma treatment, and hepatocellular carcinoma pharmacotherapy.

Publications per year

2020–2024

Publications

Sustained release hypoxia-activated prodrug-loaded BSA nanoparticles enhance transarterial chemoembolization against hepatocellular carcinoma

Ying-Hong Hao, Wenzhi Zhu, Jie Li et al. · Journal of Controlled Release · 2024 · 33 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +14

<p>Transarterial Chemoembolization Combined with Sorafenib in Patients with BCLC Stage C Hepatocellular Carcinoma</p>

Kaicai Liu, Ying-Hong Hao, Wei‐Fu Lv et al. · Drug Design Development and Therapy · 2020 · 28 citations · Full text

Medicine, Oncology, Pharmacology +14

1–2 of 2